Matches in Wikidata for { <http://www.wikidata.org/entity/Q90693761> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q90693761 description "clinical trial" @default.
- Q90693761 description "ensayo clínico" @default.
- Q90693761 description "ensayu clínicu" @default.
- Q90693761 description "klinisch onderzoek" @default.
- Q90693761 description "клінічне випробування" @default.
- Q90693761 name "Effect of TAK-071 on Falls in Patients With Parkinson Disease" @default.
- Q90693761 name "Effect of TAK-071 on Falls in Patients With Parkinson Disease" @default.
- Q90693761 type Item @default.
- Q90693761 label "Effect of TAK-071 on Falls in Patients With Parkinson Disease" @default.
- Q90693761 label "Effect of TAK-071 on Falls in Patients With Parkinson Disease" @default.
- Q90693761 prefLabel "Effect of TAK-071 on Falls in Patients With Parkinson Disease" @default.
- Q90693761 prefLabel "Effect of TAK-071 on Falls in Patients With Parkinson Disease" @default.
- Q90693761 P1050 Q90693761-4E219102-F34B-42C1-9DC7-D153BC306BC0 @default.
- Q90693761 P1132 Q90693761-7957C969-A17A-4CB3-9E29-3CA7C95C8345 @default.
- Q90693761 P1476 Q90693761-0FBE2E83-AF17-42A0-9C89-41D7805BF935 @default.
- Q90693761 P2899 Q90693761-EEEE47EA-09C3-471E-9E4F-30E1984CB938 @default.
- Q90693761 P3098 Q90693761-D74BF95C-C3C1-4210-AF86-7C9AC8E0F989 @default.
- Q90693761 P31 Q90693761-6CAF9EFB-951C-403D-B6D0-9B6503339035 @default.
- Q90693761 P4135 Q90693761-457DE628-D602-4EAF-AD2A-4765BC33A2F9 @default.
- Q90693761 P580 Q90693761-75776B49-57A4-4E73-A255-7EF470B3978D @default.
- Q90693761 P582 Q90693761-568561AD-9226-4EEF-A0C7-565D8234A9B6 @default.
- Q90693761 P6099 Q90693761-C7CBBEE0-2934-4E82-9337-013898E0A721 @default.
- Q90693761 P8363 Q90693761-F6EF8D42-7EEE-408E-94D7-C9F606616F62 @default.
- Q90693761 P921 Q90693761-128640AF-5C36-4BDA-90B3-212196FF7820 @default.
- Q90693761 P1050 Q11085 @default.
- Q90693761 P1132 "+64" @default.
- Q90693761 P1476 "A Randomized, Double-blind, Placebo-Controlled, 2-Period Crossover, Phase 2 Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral TAK-071 in Parkinson Disease Patients With Cognitive Impairment and an Elevated Risk of Falls" @default.
- Q90693761 P2899 "+40" @default.
- Q90693761 P3098 "NCT04334317" @default.
- Q90693761 P31 Q30612 @default.
- Q90693761 P4135 "+75" @default.
- Q90693761 P580 "2020-06-30T00:00:00Z" @default.
- Q90693761 P582 "2022-03-31T00:00:00Z" @default.
- Q90693761 P6099 Q42824440 @default.
- Q90693761 P8363 Q78089383 @default.
- Q90693761 P921 Q701216 @default.